Article
WASF2 Overexpression and Promoter Hypomethylation Are Associated With Poor Clinical Outcomes in Hepatocellular Carcinoma
2021-11-12
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Hepatocellular carcinoma (HCC) is one of the most common and lethal cancers worldwide. Wiskott-Aldrich syndrome protein family member 2 (WASF2) is an integral member of the actin cytoskeleton pathway that plays a crucial role in cell motility. In this study, we aimed to explore the role of WASF2 in HCC carcinogenesis and its regulatory mechanism. <bold>Methods:<...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0eb0f583-5ad1-5a38-8ca6-3623b244777f
- DOI
- 10.21203/rs.3.rs-1065747/v1
